Extremely bearish view with a strong recommendation to 'sell everything' and 'get the fuck out of it ASAP'. The speaker believes the company's drug 'does not work' and notes a 400% borrow rate, indicating high short interest.

The speaker calls the stock 'a short', but notes it is difficult to time because the data release for its 'biggest binary' event is 'very opaque'.

The speaker expressed a simple bullish sentiment, noting its recent favorable price action: 'SLS has been creeping up. I like it. Let's go.'